Rithm Capital Corp. Announces First Quarter 2025 Results
NEW YORK–(BUSINESS WIRE)–Rithm Capital Corp. (NYSE: RITM; “Rithm Capital,” “Rithm” or the “Company”) today reported the following information... Read more.
GrafTech Reports First Quarter 2025 Results
Delivering on Initiatives to Grow Volume, Increase Market Share and Reduce Costs BROOKLYN HEIGHTS, Ohio–(BUSINESS WIRE)–GrafTech International Ltd. (NYSE:... Read more.
Airbnb’s 2025 Tech Playbook: Digital Innovation, AI and Global ICT Strategies – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Enterprise Tech Ecosystem Series: Airbnb 2025” company profile has been added to ResearchAndMarkets.com’s... Read more.
Onc.AI Announces Presentation of Breakthrough-Designated AI Model Evaluated in Clinical Trial Data at AACR 2025
Serial CTRS (CT Response Score) improves prediction of overall survival compared to RECIST 1.1 and Tumor Volume Change in advanced NSCLC CHICAGO–(BUSINESS... Read more.
Lazard Reports First-Quarter 2025 Results
Financial Advisory Managing Directors total 210, achieving hiring and promotion goals outlined in the Lazard 2030 Strategic Plan Asset Management launched three... Read more.
SmartStop Self Storage Expands Digital Capabilities With Mobile App Rollout Across All Locations
LADERA RANCH, Calif.–(BUSINESS WIRE)–SmartStop Self Storage REIT, Inc. (“SmartStop”) (NYSE:SMA), an internally managed real estate investment trust... Read more.
Carter’s, Inc. Reports First Quarter Fiscal 2025 Results
Net sales $630 million vs. $661 million in Q1 2024 Diluted EPS $0.43 vs. $1.04 in Q1 2024; adjusted diluted EPS $0.66 vs. $1.04 in Q1 2024 Returned $29 million to... Read more.
Motive Wins Omnitracs Lawsuit
Jury rules for Motive against Omnitracs’ patents SAN FRANCISCO–(BUSINESS WIRE)–Yesterday, Motive, the AI-powered Integrated Operations Platform, emerged... Read more.
Booz Allen and Meta Successfully Demonstrate AI Vision Language Model for Space
Space Llama speeds ability to make critical repairs on ISS National Lab, powered by NVIDIA CUDA GPUs MCLEAN, Va. & MENLO PARK, Calif.–(BUSINESS WIRE)–Booz... Read more.
InnoCare Announces Approval of Orelabrutinib for the First-line Treatment of CLL/SLL in China
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, announced today that its BTK inhibitor orelabrutinib... Read more.